Belcher Pharmatech

Belcher Pharmatech is a specialty pharmaceutical company headquartered in Largo, Florida, dedicated to the development, manufacturing, and commercialization of complex generic and niche branded drug products. The company specializes in injectable formulations and oral solid dosage forms, operating a state-of-the-art facility that complies with current Good Manufacturing Practices (CGMP). Belcher Pharmatech maintains a diverse pipeline of Abbreviated New Drug Applications (ANDAs) and provides comprehensive contract development and manufacturing (CDMO) services. Their commercial portfolio features critical care products, including the first FDA-approved generic version of ReoPro (Abciximab). The organization focuses on addressing unmet medical needs through high-quality, cost-effective therapeutic solutions.